Search
Filter Results
Displaying 521–530 of 737 for “retinitis clinical trial”
-
Jun 27, 2024
Karen Petrou Appointed as Board Chair of the Foundation Fighting Blindness
Foundation NewsDavid Brint retires after eight years of distinguished service; Petrou to lead effective July 1, 2024.
-
May 22, 2024
Foundation NewsAdvancing Research Solutions for PRPH2-Associated Retinal Diseases.
-
Foundation Fighting Blindness Clinical Consortium
The Foundation Fighting Blindness Clinical Consortium is a not-for-profit alliance of retinal disease specialists and geneticists committed to accelerating development of efficacious treatments for inherited retinal diseases (IRDs).
-
Apr 8, 2024
What Does “Blindness” Really Mean?
Beacon StoriesJenny Schisler has retinitis pigmentosa. Jenny wants to spread awareness of what having a visual impairment really means to her and others affected by retinal degenerative diseases.
-
Feb 13, 2024
Foundation NewsThe free, online event on March 20, 2024, will feature presentations from Rachel Huckfeldt, MD, PhD, Mass Eye and Ear, and Rachelle Lin, OD, Ketchum University.
-
Feb 2, 2024
Eye on the Cure Podcast | Episode 61: Dr. Jose Sahel
Eye on the CureDr. Jose Sahel, one of the most honored and accomplished leaders in the retinal disease research space, talks with host Ben Shaberman about his establishment and leadership of renowned ophthalmology clinical research centers at the University of Pittsburgh Medical Center and Institut de la Vision in Paris. They also discuss emerging inherited retinal disease therapies from SparingVision, a biotech co-founded by Dr. Sahel.
-
The goal of Envisioning a Path to Hope is to expand connections with eye care professionals all over the U.S. This important initiative will provide an opportunity for all of our volunteers and partners to share the Foundation with eye care professionals within their personal network.
-
Nov 10, 2023
Eye on the Cure Podcast | Episode 56: Michael Voevodsky, MBA, CEO
Eye on the CureMichael Voevodsky, MBA, CEO at MitoChem Therapeutics, talks to host Ben Shaberman about his company’s emerging, gene-agnostic treatment designed to boost mitochondrial function for preserving vision in people with retinitis pigmentosa, age-related macular degeneration, and other retinal conditions.
-
Nov 2, 2023
Foundation NewsFirst of its Kind Collaboration Marries Genomics Data with World’s Largest Database of Ophthalmologic Patient Encounters to Improve Accuracy of Clinical Research.
-
Oct 16, 2023
Finding the “Keys to the Kingdom”
Beacon StoriesTricia Waechter, who has retinitis pigmentosa (RP), refers to her white canes as the “keys to the kingdom.” Using a white cane has opened a whole new world for Tricia, and that is why her company, Blind Girl Designs, includes white canes on many of their apparel designs.